Search clinical trials for: Vitamin-K Antagonists

Total 32722 results

Children's Hospital of Fudan University

Not yet recruiting

Rivaroxaban for Children With Giant Coronary Artery Aneurysms After Kawasaki Disease

Kawasaki Disease | Coronary Artery Aneurysm

China
Tasly GeneNet Pharmaceuticals Co., Ltd

Recruiting

A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A

Charcot-Marie-Tooth Type 1A

China
China National Center for Cardiovascular Diseases

Recruiting

Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus

Ventricular Thrombus

China
Academisch Medisch Centrum - Universiteit van Amsterdam...
Sahlgrenska University Hospital, Sweden; University of Helsinki; Hospital de...

Recruiting

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis (DOAC-CVT)

Cerebral Venous Thrombosis

Netherlands
GUALTIERO PALARETI
Arianna Anticoagulazione Foundation

Recruiting

START-Register: Survey on Anticoagulated Patients Register

Atrial Fibrillation | Venous Thromboembolism | Heart Valve Diseases or Prosthesis

Italy
Bayer
Janssen Scientific Affairs, LLC

Completed

Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France (BROTHER)

Atrial Fibrillation

France
University Hospital, Basel, Switzerland

Completed

New Oral Anticoagulants (NOAC) in Stroke Patients (NOACISPLongTer)

Stroke | Atrial Fibrillation

Switzerland
CHAD

Terminated

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register) (START-Portugal)

Atrial Fibrillation | Venous Thromboembolism | Heart Valve Diseases or Prosthesis

Portugal
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Terminated

Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants (VERDICT)

Renal Insufficiency

France
Population Health Research Institute
Bayer; University of Cape Town

Completed

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority (INVICTUS-VKA)

Rheumatic Heart Disease

Botswana, Philippines, Zimbabwe, India, China, Egypt, Ethiopia, Uganda, Brazil, South Africa, Cameroon, Tanzania, Kenya, Zambia, Kazakhstan, Kyrgyzstan, Malawi, Mexico, Mozambique, Nepal, Nigeria, Pakistan, Paraguay, Rwanda, Sudan
University Hospital, Essen

Completed

Registration of Idarucizumab for Patients With IntraCranial Hemorrhage (RIC-ICH)

Intracranial Hemorrhage

Germany
Assistance Publique - Hôpitaux de Paris

Completed

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over (PRESAGE-ACO)

Atrial Fibrillation

France
Bayer

Completed

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care (BEST-AF)

Atrial Fibrillation

United Kingdom
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University of Bologna

Completed

DULCIS (D-dimer and ULtrasonography in Combination Italian Study) (DULCIS)

Venous Thromboembolism

Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Italian Federation of Anticoagulation Clinics (FCSA)

Completed

D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence

Deep Vein Thrombosis | Pulmonary Embolism

Italy
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ENTRUST-AF-PCI)

Atrial Fibrillation

Italy, Netherlands, Spain, Korea, Republic of, Portugal, Hungary, Serbia, United Kingdom, Germany, Belgium, Taiwan, Austria, Switzerland, France, Ukraine, Lithuania, Poland, Romania
Bayer
Janssen Research & Development, LLC

Terminated

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes (GALILEO)

Transcatheter Aortic Valve Replacement

Belgium, France, Germany, Spain, United States, Switzerland, Canada, Austria, United Kingdom, Korea, Republic of, Denmark, Italy, Netherlands, Poland, Czechia, Sweden, Norway
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE (HOKUSAIpostVTE)

Quality of Life | Post Thrombotic Syndrome | Chronic Thromboembolic Pulmonary Hypertension | Venous Thromboembolic Disease

Netherlands
Boehringer Ingelheim

Completed

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

Atrial Fibrillation

Germany
Johannes Gutenberg University Mainz
Sanofi; Bayer; Boehringer Ingelheim; German Federal Ministry of Education and Research and other collaborators

Completed

Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme (thrombEVAL)

Atrial Fibrillation | Venous Thromboembolism | Anticoagulant Antagonists, Vitamin K and Other Coagulants Causing Adverse Effects in Therapeutic Use

Germany
Bayer
Janssen Research & Development, LLC

Completed

Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

Atrial Fibrillation

Spain
Capital Medical University

Completed

The Effects of Gabapentin Premedication on Neurosurgery

Cerebral Tumor

China
Janssen Scientific Affairs, LLC
Bayer

Completed

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention (PIONEER AF-PCI)

Atrial Fibrillation | Percutaneous Coronary Intervention

United States, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Argentina, Mexico, Bulgaria, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic of, Australia, Canada, Netherlands, Denmark and more
Medical University of Warsaw

Unknown

MultiCenter expeRience in AFib Patients Treated With OAC (CRAFT) (CRAFT)

Atrial Fibrillation

Poland
Centre Hospitalier Universitaire, Amiens

Unknown

Aortic Calcification and Vitamin K Antagonists (AVKAL)

Vascular Calcification

France
University of Padova

Completed

Optimal Duration of Anticoagulation in Deep Venous Thrombosis (MORGAGNI)

Deep Vein Thrombosis of Lower Limb | Lower Extremity Deep Venous Thrombosis Recurrent

Italy
Bayer
Janssen, LP

Completed

Real-Life Evidence on Stroke Prevention in SPAF (RELIEF)

Atrial Fibrillation (Prevention of Stroke)

Germany
Johann Wolfgang Goethe University Hospital

Completed

Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome

Antiphospholipid Syndrome

Germany
University Medical Center Groningen

Terminated

Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism (Longheva)

Neoplasms | Venous Thromboembolism

Netherlands, United States, Canada, Italy, Germany
Vivencio Barrios
Bayer

Completed

INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA) (PAULA)

Atrial Fibrillation and Flutter
Danisco

Completed

Vitamin K2 Intervention in Patients With Vitamin K Antagonists (SAFEK)

Thrombosis

France
Hospital Universitari de Bellvitge
LEO Pharma

Completed

Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis

Venous Thromboembolism

Spain
Merck Sharp & Dohme LLC

Not yet recruiting

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

Metastatic Breast Cancer
Ain Shams University

Recruiting

The Effect of Adding Either Propofol or Ketamine to Magnesium and Lidocaine Infusions in Nasal Surgeries.

Intraoperative Bleeding

Egypt
Tufts University

Not yet recruiting

Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus

Oral Lichen Planus | Oral Lichenoid Reaction

United States
Zhuhai Beihai Biotech Co., Ltd

Not yet recruiting

An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects

Bioavailability
Milky Kohno
Portland VA Medical Center

Recruiting

Sex Differences in Trauma, Inflammation and Brain Function and the Implications for Treatment Efficacy in Alcohol Use Disorder (ABSTAIN)

Alcohol Use Disorder

United States
Fundación Santiago Dexeus Font
Regen Lab SA

Not yet recruiting

Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit (CellularMatrix)

Genitourinary Syndrome of Menopause

Spain
Etlik Zubeyde Hanım Women's Health Care, Training...

Not yet recruiting

Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density (AMH)

Polycystic Ovary Syndrome | Diet Habit | AMH | Ovarian Failure
West China Hospital

Recruiting

Fruquintinib Plus S-1 and Raltitrexed (RSF) for mCRC

Fruquintinib | S-1 | Raltitrexed

China
Celgene

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma (GOLSEEK-2)

Lymphoma, Follicular

United States, Australia, Brazil, Canada, Chile, France, Germany, Italy, Korea, Republic of, Poland, Spain, Taiwan, United Kingdom
Ewha Womans University Seoul Hospital

Not yet recruiting

Comparison of the Improvement and Safety of the Ankle Brachial Arterial Pressure Index of Sarpogrelate and Clopidogrel in Stroke Patients With Decreased Ankle Brachial Arterial Pressure Index and Intermittent Claudication of Lower Limb Vascular Atherosclerosis.

Stroke | Atherosclerosis
Mayo Clinic

Not yet recruiting

Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes

PreDiabetes

United States
Tanta University

Recruiting

Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Pediatrics Undergoing Squint Surgeries

Postoperative Nausea and Vomiting | Pediatrics | Squint | Ondansetron Lozenge

Egypt
Tanta University

Recruiting

Preoperative Ondansetron Lozenge for Prevention of Post-Spinal Shivering in Caesarean Section

Cesarean Section | Ondansetron Lozenge | Post-Spinal Shivering

Egypt
AstraZeneca
Premier HealthCare Solutions Inc.

Recruiting

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care (ANCHOR)

Asthma

United States
Radboud University Medical Center

Not yet recruiting

The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II (RAID-II)

Inflammation | Diabetes Mellitus, Type 1
Odense University Hospital
University of Ulm; University of Birmingham; Hospital of South West Jutland

Not yet recruiting

Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease (RIGID)

Osteoporosis Secondary

Denmark
Yanyan Liu

Recruiting

Linperlisib Combined With Chidamide in Patients With PTCL

Peripheral T-cell Lymphoma

China
British University In Egypt

Not yet recruiting

Efficacy of Thyme Honey in The Management of Oral Aphthous Ulcers

Treatment Compliance | Aphthous Stomatitis (Major) (Minor)

Egypt

Search clinical trials for: Vitamin-K Antagonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations